© 2006 VistaGen Therapeutics, Inc.
Home Contact
   Home
   Contact
This page lists relevant publications, which relate to VistaGen's technologies and drug programs in the fields of stem cell biology, CNS drug development and metabolic diseases.

Click on the title to view or download the PDF document.

   Stem Cell Related
  1. Human cardiovascular progenitor cells develop from embryonic-stem-cell-derived population
    Yang, et al. Nature 2008

  2. Identification and targeting of the ROSA26 locus in human embryonic stem cells
    Irion et al. Nat. Biotechnol. 2007;epub:1-6

  3. The Stem Cell Revolution
    Pooley Canadian Business 2006;30-35

  4. BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm
    Gouon-Evans et al. Nat. Biotechnol. 2006;24:1402-1411

  5. Multipotent Flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages
    Kattman et al. Dev. Cell 2006;11:723-732

  6. Wnt and TGF-beta signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells
    Gadue et al. Proc Natl Acad Sci USA 2006;103:16806-16811

  7. Human embryonic stem cells: The future is now
    Keller & Snodgrass J. Exp. Med.1999;5:151-152

  8. Embryonic stem cells and in vitro hematopoiesis
    Snodgrass et al. J. Cell. Biochem.1992;49:225-230

  9. Life span of multipotential hematopoietic stem cells in vivo
    Keller & Snodgrass J. Exp. Med.1990;171:1407-1418

   Drug Development Related

 
 
Publications